UBS Group completed its issuance of USD 2 billion in aggregate principal amount of fixed rate/fixed rate senior notes due August 2027 under its senior debt programme. The notes are bail-inable (TLAC) bonds that are eligible
The Renaissance Investment Foundation has become a long-term majority shareholder in the capital of bb trading werbeartikel, the distributor of promotional items and customer gifts in Switzerland. CMS Switzerland provided comprehensive legal and tax
Kantonsspital St. Gallen, a public-law institution, launched and priced its issuance of CHF 275 million in aggregate principal amount of CHF 150 million 0.30% bonds 2021-2036 and CHF 125 million 0.05% bonds 2021-2031. The bonds have been offered in full
Thommen-Furler – the parent company of a group specializing in the fields of distribution of chemicals, specialties and lubricants, environmental technology and the disposal and recycling of industrial and hazardous waste with a turnover of approx,
Bär & Karrer successfully defeated a challenge brought against a multimillion LCIA Award for alleged violations of public policy and right to be heard. In its decision dated 15 June 2021 in case 4A_530/2020, the Swiss
Nater Dallafior represents a globally operating corporation – being the policyholder – against one of its insurers in SCAI arbitration proceedings. The dispute concerns a claim for coverage based on a business liability insurance policy. The value
Atlas Antibodies, a global developer of advanced reagents for biomedical research based in Sweden, has agreed to acquire Evitria Group from its shareholders. The transaction closed on August 5, 2021. Vischer advised the sellers on this
The Swiss e-commerce agency and software house specializing in the design, development and operation of e-commerce solutions for SMEs, MySign has becomes part of the German Allgeier Group. The IT and software services company Allgeier
UBS, acting through its London branch, successfully completed its issuance of (i) USD 1 bn aggregate principal amount of Floating Rate Notes due August 2024, and (ii) USD 1 bn aggregate principal amount of 0.70 per cent. Notes due
WuXi STA, a subsidiary of WuXi AppTec, a pharmaceutical development and manufacturing capability and technology platform company, whose shares are listed on the Shanghai Stock Exchange and the Hong Kong Stock Exchange, completed the acquisition
